Turning and Turning In The Widening Iatrikē

Turning and turning in the widening iatrikē

Waiting for my morning medication. Waiting for my evening medication. Since 2010 I have been dependant on large dosages of psychiatric medications and since 2021 neurological medication were added. I spend R3000 a month on medication and it does not cure me, it only slightly subdue the symptoms of illnesses that will not go away. Pharmaceutical companies generate substantial revenue from the sale of psychiatric medications each year. The global market for psychiatric drugs, which includes medications for conditions such as depression, anxiety, bipolar disorder, schizophrenia, and other mental health issues, is significant and has been growing steadily.

As of recent estimates, the global psychiatric drugs market was valued at around $88 billion in 2020 and is projected to continue growing. Factors contributing to this growth include increasing awareness and diagnosis of mental health conditions, the development of new and more effective medications, and a growing acceptance of mental health treatment in various regions.

. The global epilepsy drug market is a multi-billion-dollar industry, driven by the ongoing need for antiepileptic drugs (AEDs) to manage and control seizures in individuals with epilepsy.

As of the most recent data, the global epilepsy drug market was valued at approximately $4 billion annually. This market is expected to grow steadily due to factors such as the increasing prevalence of epilepsy, advancements in drug development, and the introduction of new and more effective medications. The market is projected to reach around $6 billion by 2027, growing at a compound annual growth rate (CAGR) of about 5-6%.